[Severe heart failure--effects of carvedilol therapy. The Copernicus Study]

Internist (Berl). 2002 Feb;43(2):284-6. doi: 10.1007/s00108-001-0515-3.

[Article in German]

Authors

M Kindermann¹, M Böhm

Affiliation

¹ Innere Medizin III (Kardiologie/Angiologie), Universitätskliniken des Saarlandes, 66421 Homburg.

PMID: 11963765
DOI: 10.1007/s00108-001-0515-3

No abstract available

MeSH terms

Adrenergic beta-Antagonists / adverse effects
Adrenergic beta-Antagonists / therapeutic use*
Carbazoles / adverse effects
Carbazoles / therapeutic use*
Carvedilol
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Heart Failure / drug therapy*
Heart Failure / mortality
Humans
Propanolamines / adverse effects
Propanolamines / therapeutic use*
Prospective Studies
Randomized Controlled Trials as Topic
Survival Rate
Treatment Outcome

Substances

Adrenergic beta-Antagonists
Carbazoles
Propanolamines
Carvedilol